SC
ELV icon

Schubert & Co’s Elevance Health ELV Stock Holding History

Schubert & Co’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-24
Closed -$11K – 494
2023
Q1 		$11K Sell
24
-10
-29% -$4.76K 0.01% 205
2022
Q4 		$17.4K Buy
34
+5
+17% +$2.54K 0.02% 126
2022
Q3 		$13K Sell
29
-2
-6% -$957 0.01% 153
2022
Q2 		$15K Buy
31
+16
+107% +$7.92K 0.01% 134
2022
Q1 		$7K Buy
15
+2
+15% +$914 0.01% 134
2021
Q4 		$6K Buy
+13
New +$5.47K 0.01% 124

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Schubert & Co's ELV Position: Q2 2023 in Review

Schubert & Co sold out of Elevance Health (ELV) in Q2 2023, closing a stake of 24 shares — an estimated $11K sold.

Schubert & Co first reported a position in ELV in Q4 2021 and held it in 6 quarters. The position peaked at $17.4K in Q4 2022. 1,523 funds tracked by Wall St. Rank hold ELV as of Q2 2023.

  • Schubert & Co reported no remaining Elevance Health position as of Q2 2023 after selling out during the quarter.
  • Schubert & Co sold 24 Elevance Health shares in Q2 2023, an estimated $11K.
  • Schubert & Co first reported a position in Elevance Health in Q4 2021 and held it in 6 quarters.
  • Schubert & Co's Elevance Health position peaked at $17.4K in Q4 2022.
  • 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.